Lancet has the details. I’ve only read the abstract, so don’t know much about the actual research. Study subjects were sub-optimally controlled (HgbA1c of 8-12%) on multiple daily injections; that’s why they were considered for pump therapy. They were randomized to pump or continued multiple daily injections. What I can’t tell – and it matters – is whether the multiple injection group underwent changes in their management or whether they were told to “just keep doing what your were doing” (which wasn’t working well).